COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Multiple vaccines have recently been developed, and almost all the countries are presently
vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 …
vaccinating their population to tackle the COVID-19 pandemic. Most of the COVID-19 …
Bacterial membrane vesicles for vaccine applications
Vaccines have been highly successful in the management of many diseases. However,
there are still numerous illnesses, both infectious and noncommunicable, for which there are …
there are still numerous illnesses, both infectious and noncommunicable, for which there are …
Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
AD Moura, HHM da Costa, VA Correa… - Scientific Reports, 2021 - nature.com
SARS-CoV-2 is considered a global emergency, resulting in an exacerbated crisis in the
health public in the world. Although there are advances in vaccine development, it is still …
health public in the world. Although there are advances in vaccine development, it is still …
Vaccines, adjuvants and key factors for mucosal immune response
VA Correa, AI Portilho, E De Gaspari - Immunology, 2022 - Wiley Online Library
Vaccines are the most effective tool to control infectious diseases, which provoke significant
morbidity and mortality rates. Most vaccines are administered through the parenteral route …
morbidity and mortality rates. Most vaccines are administered through the parenteral route …
Biological nanoparticles in vaccine development
SM Curley, D Putnam - Frontiers in Bioengineering and …, 2022 - frontiersin.org
Vaccines represent one of the most successful public health initiatives worldwide. However,
despite the vast number of highly effective vaccines, some infectious diseases still do not …
despite the vast number of highly effective vaccines, some infectious diseases still do not …
Outer membrane vesicles: An emerging vaccine platform
Vaccine adjuvants are substances that improve the immune capacity of a recombinant
vaccine to a great extent and have been in use since the early 1900s; they are primarily …
vaccine to a great extent and have been in use since the early 1900s; they are primarily …
Coronavirus disease (COVID-19) control between drug repurposing and vaccination: a comprehensive overview
Respiratory viruses represent a major public health concern, as they are highly mutated,
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
Recent advances in various bio-applications of bacteria-derived outer membrane vesicles
L Sadeghi, E Mohit, S Moallemi, FM Ahmadi… - Microbial …, 2023 - Elsevier
Outer membrane vesicles (OMVs) are spherical nanoparticles released from bacteria. OMVs
were originally classified into native 'nOMVs'(produced naturally from budding of bacteria) …
were originally classified into native 'nOMVs'(produced naturally from budding of bacteria) …
Vaccine Strategies to Elicit Mucosal Immunity
Y Song, F Mehl, SL Zeichner - Vaccines, 2024 - mdpi.com
Vaccines are essential tools to prevent infection and control transmission of infectious
diseases that threaten public health. Most infectious agents enter their hosts across mucosal …
diseases that threaten public health. Most infectious agents enter their hosts across mucosal …
Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring
AI Portilho, H Hermes Monteiro da Costa… - Human Vaccines & …, 2024 - Taylor & Francis
ABSTRACT COVID-19, caused by SARS-CoV-2, and meningococcal disease, caused by
Neisseria meningitidis, are relevant infectious diseases, preventable through vaccination …
Neisseria meningitidis, are relevant infectious diseases, preventable through vaccination …